Clinical Characteristics
Ultralow
(N=834)
Low
(N=2201)
High 1
(N=2175)
High 2
(N=568)
Overall
(N=5778)
P-value
Age (Years)
Mean (SD) 62 (± 11) 61 (± 11) 60 (± 13) 57 (± 13) 60 (± 12) <0.001
Menopausal Status
Post 658 (78.9%) 1682 (76.4%) 1575 (72.4%) 386 (68.0%) 4301 (74.4%) <0.001
Pre/Peri 140 (16.8%) 418 (19.0%) 478 (22.0%) 145 (25.5%) 1181 (20.4%)
Unknown 36 (4.3%) 101 (4.6%) 122 (5.6%) 37 (6.5%) 296 (5.1%)
Tumor Stage
multifocal/bilateral 1 (0.1%) 7 (0.3%) 4 (0.2%) 4 (0.7%) 16 (0.3%) <0.001
T1 527 (63.2%) 1322 (60.1%) 1071 (49.2%) 207 (36.4%) 3127 (54.1%)
T2 106 (12.7%) 354 (16.1%) 553 (25.4%) 210 (37.0%) 1223 (21.2%)
T3 5 (0.6%) 33 (1.5%) 60 (2.8%) 22 (3.9%) 120 (2.1%)
T4 2 (0.2%) 8 (0.4%) 20 (0.9%) 11 (1.9%) 41 (0.7%)
Unknown/Missing 193 (23.1%) 477 (21.7%) 467 (21.5%) 114 (20.1%) 1251 (21.7%)
LN Stage
multifocal/bilateral 2 (0.2%) 2 (0.1%) 3 (0.1%) 2 (0.4%) 9 (0.2%) <0.001
N0 536 (64.3%) 1419 (64.5%) 1272 (58.5%) 319 (56.2%) 3546 (61.4%)
N1 68 (8.2%) 230 (10.4%) 341 (15.7%) 111 (19.5%) 750 (13.0%)
N2 2 (0.2%) 11 (0.5%) 20 (0.9%) 9 (1.6%) 42 (0.7%)
N3 1 (0.1%) 4 (0.2%) 7 (0.3%) 6 (1.1%) 18 (0.3%)
Unknown/Missing 225 (27.0%) 535 (24.3%) 532 (24.5%) 121 (21.3%) 1413 (24.5%)
Grade
G1 472 (56.6%) 900 (40.9%) 330 (15.2%) 12 (2.1%) 1714 (29.7%) <0.001
G2 309 (37.1%) 1100 (50.0%) 1279 (58.8%) 163 (28.7%) 2851 (49.3%)
G3 9 (1.1%) 105 (4.8%) 455 (20.9%) 370 (65.1%) 939 (16.3%)
multifocal/bilateral 14 (1.7%) 28 (1.3%) 25 (1.1%) 10 (1.8%) 77 (1.3%)
Unknown 30 (3.6%) 68 (3.1%) 86 (4.0%) 13 (2.3%) 197 (3.4%)
BP Subtype
Basal 0 (0%) 0 (0%) 21 (1.0%) 234 (42.4%) 255 (4.6%) <0.001
HER2 0 (0%) 0 (0%) 1 (0.0%) 4 (0.7%) 5 (0.1%)
Luminal A 809 (100%) 2117 (100%) 0 (0%) 0 (0%) 2926 (52.7%)
Luminal B 0 (0%) 0 (0%) 2053 (98.9%) 314 (56.9%) 2367 (42.6%)